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Abstract It has recently been suggested that, rather than
being an autoimmune disease, multiple sclerosis (MS) is an
example of a neurocristopathy, a pathological process
resulting from a faulty development of the neural crest.
Whilst several characteristics of the disease suggest a
neurocristopathy, other aetiological factors require con-
sideration, including hygiene-related factors that alter the
immune responses to common pathogens resulting in an
eclipse of immune reactivity that could protect against MS,
the possible role of human endogenous retroviruses
(HERVs) in pathogenesis and autoimmune phenomena,
HLA polymorphism, vitamin D levels before and after
birth and immune repair mechanisms. A postulated aetio-
logical factor in MS, associated with altered vitamin D
metabolism and abnormal HERV expression, is a long-
lasting disturbed redox regulation in the biosynthesis of a
melanoma-like melanin pigment. Although intensive fur-
ther studies on melanin pigments in nerve tissue in MS are
required, the known properties of a pathological form of
such pigments in melanoma could explain a number of
observations in MS, including the impact of light,
UV-light, and vitamin D, and could explain the clinical
manifestations of MS on the basis of an oscillating process
of oxidative charge and discharge of the pigments and a
threshold phenomenon with a change of the quasi-catalytic
function of the pigment from destroying reactive oxygen
radicals or species to transforming them to more harmful
long-persisting highly reactive species. Taken together
with the consequences of an adaptive process in partly
demyelinated neurons, resulting in an increase in number
of mitochondria, and the impact of stressful life events,
these conditions are necessary and sufﬁcient to explain the
disease process of MS with its spatial (plaques) and tem-
poral (attacks and remissions) characteristics. This
suggested unifying concept of the pathogenesis of MS may
open perspectives for prevention, diagnosis and therapy. In
particular, prevention may be achieved by vaccinating
against Epstein-Barr virus in early childhood.
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Introduction
In a recent article published in this journal, Behan and
Chaudhuri (2010) criticise the current paradigm that mul-
tiple sclerosis (MS) is primarily an autoimmune disorder
and they cite data supporting a concept of this disease
being a neurocristopathy; namely, a pathological process
resulting from a faulty development of the neural crest. We
fully agree that a reappraisal of the cause and nature of MS
is overdue but there are no less than seven major aspects
that are of critical relevance to such a reappraisal. These
are exogenous infections, human endogenous retrovirus
(HERV) activity, HLA polymorphism, immune repair,
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123autoimmunity, vitamin D levels and cell damage by reac-
tive oxygen species or radicals (ROS). As Behan and
Chaudhuri rightly remark, the concept of a neurocristopa-
thy has been more or less neglected but so has immune
repair, whilst aspects such as HERVs have been considered
largely in isolation from the other factors including the
nature and timing of exogenous infections. The time has
come to attempt to draw all the known aspects of this
complex and puzzling disease together in the hope of
paving the way to a unifying concept.
It is clear that the aetiology of MS is extremely complex
as many co-factors may interact in different ways so that
any single factor may appear to have a strong, weak or
even antagonistic effect on the risk and course of the dis-
ease. In this context, features associated with MS may be
necessary or merely enhancing or predisposing and, if
necessary, may or may not be sufﬁcient to explain the
clinical manifestations of the disease. The challenge is to
understand the roles of, and the interconnections between,
these factors. Focusing on any single factor may yield
conﬂicting data and, in general, the observed effects of
single factors in conditions with complex aetiologies are
much weaker than in those with a single cause. Large
studies are therefore needed to reveal signiﬁcant associa-
tions, and in smaller studies a non-signiﬁcant association
does not rule out a causative role.
A major challenge in MS is to understand the inﬂuences
of exposure to visible and UV-light, of the signiﬁcance of
vitamin D levels, and of the supposed core-aspect of
‘neurocristopathy’, namely, melanin. Moreover, a unifying
concept of MS must be able to give a simple explanation
for the spatial distribution of the disease (in plaques) and
the time course (attacks, remissions and demyelinating
events).
The hygiene hypothesis and Darwinian medicine
A useful starting point in an endeavour to unravel the
complexities of MS is the emerging discipline of ‘Dar-
winian medicine’ (Rook 2009; Krone and Grange 2010)
with its central concept that hygiene-related factors in the
industrialised nations increasingly isolate the human pop-
ulation from micro-organisms, both pathogens and,
probably more importantly, commensals, that are crucial to
the establishment of beneﬁcial protective immunoregula-
tory networks. This concept, sometimes termed the hygiene
hypothesis, has been advanced as an explanation for the
considerable rise in the incidence of diseases associated
with chronic inﬂammation mediated by immune dysregu-
lation, notably allergies, asthma, vasculitis, autoimmune
disorders, and some forms of cancer. Epidemiological
studies clearly indicate that MS must be numbered amongst
these environment-related conditions (Fleming and Fabry
2007), and would explain why MS occurs more often in the
northern, industrialised, regions and why those migrating at
an early age to a low-risk region take on the lower risk and
those migrating at a later age to a high-risk region do not
take on the higher risk.
A possible role for the Epstein-Barr virus
in the aetiology of MS
A meta-analysis has established that more than 95% of all
patients with MS have serological evidence of prior
Epstein-Barr virus (EBV) infection, compared to 87% of
control subjects (Santiago et al. 2010). Furthermore, there
is a lag phase of several years or a decade or more between
EBV infection and the clinical manifestation of MS (Haahr
et al. 2004). During this rather long time period, EBV-
speciﬁc antibody may well have dropped below detectable
levels in some persons. Also, taking into account the
distribution of speciﬁc antibody concentrations in the study
groups, it is not only possible but also indeed likely that
there are virtually no EBV-naı ¨ve persons in the patient
group and, accordingly, past EBV infection has been pos-
tulated as a necessary condition for development of MS
(Krone et al. 2008, 2009; Krone and Grange 2011; Pohl
et al. 2006).
There are a number of hypothetical mechanisms by
which EBV might induce MS (Ascherio and Bar-Or 2010;
Korn 2008; Perron et al. 2009; Pohl 2009), though none of
these convincingly explain the pathogenesis of the disease
and it appears more likely that other infections synergize
with EBV to produce a dysregulated immune response
years or a decade before the clinical onset of MS.
One consequence of improved hygiene in the wealthier
industrialised nations is that certain infections that were
previously regularly encountered in infancy now occur at a
much later time in life and after other infections may have
altered the patterns of immune responses elicited by the
former. Infection by EBV is a good example and it has
been postulated that infections by various other pathogens
bearing cross-reacting epitopes acquired before EBV may
affect immunoregulatory networks, thereby leading to an
attrition or eclipse of those regulatory T-cells (Tregs) that
would otherwise protect against MS (Krone et al. 2009).
Accordingly, a critical determinant of MS risk could be a
compromised number or activity of protective Tregs (Levin
et al. 2005; Brudek et al. 2009).
In this context, T-cells recognising the EBNA-1 protein
of EBV play a central immune protective role in the control
of EBV infection in healthy individuals although only a
few of the many epitopes of EBNA-1 are recognised by
T-cells. By contrast, very many more are recognised in MS
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123(Lu ¨nemann et al. 2006), and this so-called ‘epitope
spreading’, probably induced by prior infections by
pathogens bearing many cross-reactive epitopes, such as
HHV-6 and Chlamydia pneumoniae, could divert immune
responses away from protective ones.
Endogenous retroviruses
Human endogenous retroviruses have entered the human
germ line successively over millions of years (Christensen
et al. 2007; Perron and Lang 2010; Dolei and Perron 2009),
and are present in the genome of all host cells. Most
HERVs are defective, having been inactivated by negative
selection and an accumulation of mutations (deletions,
termination codons and frame shifts) and thus most of their
genetic loci are inactive (Christensen 2005, 2010). Some
reading frames have, however, remained open and code for
complete proteins, such as the ERVWE1 locus on chro-
mosome 7q21 which codes for syncytin-1, and one member
of the HERV-W family, the MS-related virus (MSRV), can
form complete virions under certain circumstances
(Mameli et al. 2007). Moreover, it is well established that
certain exogenous human retroviruses, HTLV-I and HIV,
as well as Endogenous retroviruses in other species, such as
rodents, ovines, and birds, can be cause of neurological and
malignant diseases (Weiss 2006).
The expression of ERVWE1/MSRV in brain tissue from
MS patients has been reported (Antony et al. 2007a, b;
Sotgiu et al. 2002), and the number of such expressed
sequences in the CSF has been shown to be higher in MS
than in controls (Mameli et al. 2007; Sotgiu et al. 2006;
Mameli et al. 2009). In addition, increased levels of anti-
body reactivity to speciﬁc retroviral HERV Gag and Env
epitopes have been found in serum and CSF from MS
patients (Christensen 2005), and these antibody levels are
related with the activity of the disease (Christensen et al.
2007). The HERV-W encoded Env protein (ERVWE1,
syncytin) is upregulated in glial cells in active MS lesions
and, when expressed as a construct in astrocytes, has been
shown to induce oligodendrocyte cell death via redox-
reactants (Antony et al. 2004), as well as inducing an
autoimmune cascade (Perron and Lang 2010).
Despite 20 years research, the role of HERVs as
pathogens is still controversial but, nevertheless, they are
the leading candidates for a link between genetic predis-
position and environmental factors in causing a disease
such as MS.
A potentially important link, one requiring experimental
veriﬁcation, between HERV-related phenomena and the
pathogenesis of a neurocristopathy leading to MS involves
the metabolism of melanin. This link is suggested by par-
allel observations in melanoma which have led to the
concept that over-expression of certain HERV-encoded
proteins results in metabolic changes that induce the for-
mation of pathological forms of melanin (Krone and
Grange 2010, 2011). Melanoma–melanin is very long lived
and tends to become oxidatively charged and can therefore
catalyse the formation of harmful reactive oxygen species
over a long time span, in contrast to normal melanin which
destroys such species (Tolleson 2005). Cells containing
abnormal melanin are, accordingly, vulnerable to various
forms of oxidative stress that, through damage to proteins,
lipids and chromosomes, pave the way to cell degeneration
or malignant transformation. By analogy, it is possible that
expression of ERVWE1 proteins induce the biosynthesis of
a melanoma-like melanin. In common with MS, the risk of
developing melanoma is affected by a complex infectious
background leading to the development of populations of
T-cells that recognise a HERV-encoded envelope epitope,
HERV-K-MEL (Krone and Grange 2010). In considering
such parallels, it should be noted that melanomas develop
from cells derived from the neural crest.
Vitamin D
Amongst the several environmental risk factors for MS
(Ascherio and Munger 2007), a leading one is a low level
of bioactive vitamin D3, but it is still controversial whether
any and, if so, which of the many forms and actions of this
vitamin is critical for MS (Szodoray et al. 2008; Smolders
2011). Thus, although vitamin D supplementation induced
anti-inﬂammatory cytokine production with therapeutic
beneﬁt in MS patients (Smolders et al. 2010), immune
modulating activity of this vitamin does not explain the
risk-enhancing effect of low vitamin D3 levels which
appear to commence during early in utero development as
persons born in November/December have the lowest MS
risk whilst those born in May/June have a highest risk. This
difference is statistically signiﬁcant (Willer et al. 2005).
The effect was also seen in a small group of German
patients with onset of MS in childhood (Fig. 1. Data sup-
plied by courtesy of Hanefeld 2011).
It is suggested that low levels of this vitamin cause, via
c-glutamyl-transpeptidase, a reduction in the intra-cellular
levels of glutathione, as has been demonstrated in rat
astrocytes (Garcion et al. 1999), and a restricted capacity to
reduce reactive oxygen species. The long-lasting impact of
this effect may result from a favouring of the peroxide
driven biosynthesis of melanoma-like melanin and by the
long-living nature of the polymeric melanin redox pig-
ments including pro-oxidative variants. As a consequence,
more quinone/hydroquinone subunits of the pigment tend
to be brought into the quinone form and, accordingly, the
pigment takes on a pro-oxidative charge that changes the
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oxygen species and radicals to transforming them into long
living and more harmful ones. (Furthermore the patho-
logical pigment can become reduced to a more or less
normally functioning one, although it remains at risk of
becoming pro-oxidatively charged again). It should be
noted that the charging and discharging of the pigment is
an oscillating process and that the change in the mode of
action of the pigment in relation to pro-oxidative charge is
a threshold phenomenon.
HLA polymorphism
Family studies indicate that genetic factors are involved in
the risk of developing MS. Thus, for example, in northern
countries with an overall lifetime MS risk of 0.1–0.2%, the
risk in identical twins and ﬁrst, second and third degree
relatives (with 100, 50, 25 and 12.5% genetic similarity,
respectively) are 25, 2–5, 1–2, and\1%, so that, at most,
penetrance of the risk is only 25% (Goodin 2010). The
strongest genetic risk factor is within the HLA-DRB1 locus
and, more speciﬁcally, the HLA-DRB1*1501 allele
although only a small minority of those with this allele
develop MS, suggesting that many other genetic loci are
involved in the determination of risk. Thus, the develop-
ment of MS almost certainly depends on the combination
of genetic susceptibility and environmental factors, notably
EBV infection, vitamin D levels, and hygiene-related fac-
tors (Goodin 2009). In principle, HLA haplotypes and other
genetic loci could affect risk by determining the repertoire
of microbial epitopes presented to effector cells of the
immune system and the levels and metabolism of vitamin
D (Ramagopalan et al. 2009).
Melanin, oxygen and mitochondrial damage
As discussed above, two factors appear to be involved in
the biosynthesis of a melanoma-like melanin, HERV-
related activity and low vitamin D levels. It seems that the
two act synergistically and that they must even combine to
produce the disease. Most of the vitamin D in humans is
synthesised in the uncovered skin upon exposure to bright
sunlight rich in UV-B. Reduced exposure to such light is
related to geographical latitude and, when this is experi-
enced during ﬁrst trimester in pregnancy, it already
initiates in utero a chain of events leading to the synthesis
of a very long-living melanoma-like melanin. The hygiene-
related factors leading to low intracellular glutathione
peroxidase levels may well synergise with low vitamin D
in inducing abnormal melanin synthesis and the subsequent
regulation of its functional activity.
The biosynthesis of the melanoma-like pigment in
conditions of low vitamin D levels would occur years or
decades before the clinical onset of MS. Within the nerve
cell, low glutathione peroxidase and low levels of its
substrate glutathione result in diminished ability to reduce
hydrogen peroxide and lipid peroxides. The peroxides react
with the ortho-quinone structure of melanin subunits and
its precursors and cleave the bond between the two
carbonyl-groups of some of the ortho-quinone subunits
thus generating a melanoma-like melanin (Ito and Wak-
amatsu 2008).
A switch to the pro-oxidative form of melanin is
dependent on recent low vitamin D levels in combination
with the generation of reactive oxygen species and radicals
by stressful life events. In this context, it was shown in an
Australian case–control study that past and current sun
exposure and serum vitamin D levels are independently
associated with a reduced risk of ﬁrst demyelinating events
in the central nervous system (Lucas et al. 2011), sug-
gesting that vitamin D is involved in the biosynthesis of the
pigment and on its switching to the pro-oxidative form.
Another factor affecting the biological activity of mel-
anins is the hormone melatonin which causes aggregation
Fig. 1 Seasonal MS-risk
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123of melanosomes within the cells during the night. This may
explain why manifestation of MS is observed more fre-
quently during the light months of the year with shorter
nights (Meier et al. 2010).
The concepts reviewed above shed light on the obser-
vations that exacerbations of MS are dependent on
oxidative/nitrosative stress and a diverse range of stressful
life events (Mohr et al. 2004). Furthermore, the association
between smoking and exacerbations of MS (Healy et al.
2009) could be related to the ability of nicotine to accu-
mulate in melanin-containing cells and to affect melanin
metabolism (Yerger and Malone 2006).
Molecular oxygen, which is highly reactive, is essential
for all human cells, but in particular for nerve cells as these
have no alternative ways of producing energy and, in the
absence of oxygen, will die within a few minutes and are
not replaced. Although nerve cells account for only about
2% of the body mass they consume (when body is at rest)
about 20% of all available oxygen. Oxygen-based meta-
bolic processes generate reactive oxygen species which are
normally rapidly destroyed by enzymes such as catalases
and glutathione peroxidises, processes requiring reduction
substrates, in particular, glutathione. Another important
protective factor is the melanin pigment, an important
component of the cellular microenvironment that deter-
mines the half life of ROS and which is the last barrier
against the harmful ROS when the ﬁrst lines of protection,
the endogenous antioxidant enzymes and free glutathione,
are overrun. There is increasing evidence that ROS play a
key role in the nerve damage in MS and other neurode-
generative and neuroinﬂammatory disorders, and the
possible therapeutic use of anti-oxidant agents has been
discussed (Gilgun-Sherki et al. 2004; van Horssen et al.
2011).
ROS are predominantly produced in the mitochondria as
an unwanted side effect of endoxidation, oxidative phos-
phorylation and generation of ATP (Toyomizu et al. 2010).
Accordingly any disturbance in mitochondrial function
could have adverse, even fatal, consequences for irre-
placeable nerve cells (Campbell and Mahad 2011).
Increased numbers of mitochondria within nerve cells have
been observed in active and inactive MS lesions and are
presumed to be the result of adoptive, principally protec-
tive processes (Witte et al. 2009). Moreover, it is known
that diseases of mitochondria are associated with
degenerative neurological disease, particularly, those
characterised by demyelination (Mahad et al. 2008). In this
context, ROS causes damage to axons, resulting in demy-
elination (Witte et al. 2009; Mao and Reddy 2010), with a
reduction in the ability of the axons to conduct electrical
impulses. Accordingly, the affected cells need more energy
and the number of mitochondria increases though, when
even more stressed, they produce many more ROS. The
linkbetweenstressandformationofROSisthusprovidedby
theactionofthemitochondria.Onexcessiveenergydemand,
ROSproductionbymitochondriaincreasesandthis,together
with a depression of a protective mechanism, the energy
consuming inducible proton leak, leads to a higher mito-
chondrial membrane potential with further ROS production
(Toyomizu et al. 2010). Thus, although intracellular pro-
tective mechanisms exist, if these are over-run, a massive
over-production of ROS occurs and may in part explain the
focal demyelinating lesions characteristic of MS.
A change from normal to melanoma-like melanin may
well tip the balance between protection and ROS-mediated
damage. In this context, although MS has long been
regarded as a disease initially affecting white matter of the
brain, recent studies indicate that the disease process
commences in the grey, melanin-pigmented, brain tissue
(Dalton et al. 2004; Geurts and Barkhof 2008).
Autoimmune reactions in MS—cause or consequence?
Despite considerable debate in the literature, the question
of whether MS is an autoimmune disease remains unre-
solved. It appears likely, however, that autoimmunity is a
secondary phenomenon and at least one cause could be that
some HERV-encoded proteins act as superantigens, i.e.
antigens that non-speciﬁcally mediate a wide range of
antibody responses, including autoimmune ones (Conrad
et al. 1997). In addition, as HERV proviruses are an
established part of the human genome, HERV-expressed
proteins can be regarded as ‘self’ so that any immune
responses to them could be regarded as being autoimmune
ones.
A further indication that there is an autoimmune com-
ponent to MS is the clinical response to b-interferon which
has been shown to suppress the differentiation of Th17
cells, a class of T-cells involved in many autoimmune
processes (Zhang and Markovic-Plese 2010). Also, the
antibody natalizumab appears to confer beneﬁt in MS by
preventing the transmigration of proinﬂammatory T-cells
from the peripheral blood to the central nervous system
(Kivisa ¨kk et al. 2009). As the underlying characteristic of
the various elements of MS appears to result from chronic
inﬂammation secondary to immune dysregulation, an
improved therapeutic strategy may be an adjuvant-based
immune modulating agent (Bottasso et al. 2009).
Cell repair
The ability of immune reactions to lead to the killing of
abnormal cells by, for example, cytotoxic T-cells and NK
cells is well known, but much less attention has been
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importance in situations, such as the CNS, when conser-
vation of cells is essential. One repair mechanism involves
the direct transfer of gangliosides from leucocytes to target
cells and, by mediating DNA methylation, they suppress or
silence the expression of HERV-encoded genes (Krone and
Grange 2010; Stengel et al. 2010).
An emerging paradigm?
The aspects of the pathogenesis of MS brieﬂy summarised
above emphasise that the subject is very complex and that
there are still numerous gaps in our understanding and
many loose threads that have not yet been woven together.
Nevertheless, a picture is emerging of the predisposing
factors and the chain of events that result in the clinical
expression of this disease.
These may be summarised as follows:
• The risk of MS is dependent on the ‘biography’ of the
immune system rather than on acquisition of a speciﬁc
and unusual infection. This biography is strongly
inﬂuenced by hygiene-related factors.
• This biography mediates an eclipse of MS protective
self-speciﬁc immune reactions. Candidate peptides as
possible relevant targets have been proposed on the
basis of epidemiological observations and genetic data
bank entries.
• The risk of MS is related to HLA types, suggesting that
the HLA molecules of the patients have, compared to
unaffected individuals, a reduced or absent ability to
present the relevant protective peptides to the corre-
sponding regulatory and effector T-cells.
• A likely form of immune reactivity protecting against
MS is one that is mediated by self-speciﬁc CD8?
T-cellsthatperformimmunerepairandthereby suppress
genetic expression of potentially harmful HERV genes.
• There is increasing evidence that MS is a HERV-
related disease. Expression of HERV proteins, in
particular, the ERVWE1-encoded envelope glycopro-
tein, induces a disturbed redox regulation in affected
cells.
• The putative link between HERV expression and long-
lasting disturbed redox regulation is the biosynthesis of
a melanoma-like melanin pigment that tends to become
oxidatively charged and to catalyse the formation of
long-persisting highly reactive radicals and oxygen
species. Vitamin D levels and HLA-related regulation
of this vitamin, before and after birth, may affect
melanin metabolism.
• As superantigens, HERV antigens can also induce
autoimmune reactions as secondary phenomena in MS.
It should be noted that these key elements form a chain
of events which, with the possible exception of the last one,
autoimmunity, lead eventually to the manifestation of
clinical disease. On the other hand, although these key
factors are collectively, though not individually, necessary,
they must be considered in the context of a putative key
element, namely a ‘neurocristopathy’, resulting from
abnormal melanin metabolism.
Applying Occam’s razor, the clinical manifestation of
MS as a focal demyelinating disorder can be considered in
the ‘front scenery’ of the disease as the consequence of
three conditions—based on the factors outlined above—
that combine with stressful events in life. First, an oscil-
lating reaction in which normal melanin and, to a greater
extent, abnormal melanin tends to become pro-oxidatively
charged, with this charge being normalised by the gluta-
thione-based reactions described above. Such oscillating
reactions, illustrated by the Belousov–Zhabotinskii reac-
tion, occur in various biological situations (Quo and Wang
2008). Second, a threshold is encountered at which, instead
of destroying ROS, the abnormal pigment transforms them
into longer living and more harmful ones. Finally, when the
cell undergoes metabolic stress as a result of excessive
energy demand, mitochondrial dysfunction ensues and, in
cells with high numbers of mitochondria, massive amounts
of ROS are produced. If transformed to long-living ones,
there is ensuing cell damage, in particular, demyelination.
In addition to critically reviewing current concepts in
MS, Behan and Chaudhuri (2010) review the evidence that
MS is associated with a higher incidence of other neuro-
logical diseases such as malignant glioma, glioblastoma
multiforme, neuroﬁbromatosis Type I, and hypertrophic
peripheral neuropathy, all of which develop in cells derived
from the same progenitor glial cells. They also point to the
high incidence of multicentric origin of these diseases in
patients with MS. A possible cause, in addition to those
suggested by Behan and Chaudhuri, and especially of glial
malignancies, is a widespread disturbance in gene expres-
sion and metabolic activity in these cells secondary to over-
expression of HERVs. There is a deﬁnite association
between HERV expression and many cancers and the
various mechanisms by which HERV expression can lead
to genetic instability resulting in malignant transformation
have been reviewed (Romanish et al. 2010).
The steps, albeit speculative, towards a unifying concept
of the pathogenesis of MS suggested here may open the
perspective for immune prevention of this disease by
vaccinating against EBV in early childhood (Krone et al.
2009). Furthermore, they give a rationale for the estab-
lished diagnosis of MS based on patterns and levels of
speciﬁc antibodies against commonly encountered patho-
genic viruses in the central nervous system (Reiber et al.
2009) and for the prognostic value of the amount of
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brain (Antony et al. 2006; Mameli et al. 2009). They also
point to an increased importance in early MS, or before the
clinical onset of MS, of retinal examination to detect
pathological changes attributable to altered melanin
(Graham et al. 1989).
Furthermore, they provide pointers to the development
of preventive and therapeutic strategies for MS based on
the concept of a neurocristopathy, in particular, involving
the biosynthesis and bioactivity of melanoma-like melanin
redox pigments (Krone and Grange 2011), with putative
critical importance for exacerbations of MS that are
observed to be dependent on oxidative/nitrosative stress
and a diverse range of stress reactions (Mohr et al. 2004).
In particular, vitamin D and other anti-oxidative vitamins
may play a greater therapeutic role in the future. The
concept also sheds rationality on therapeutic attempts to
remove heavy metal ions, in particular, mercury and iron,
which are incorporated into the melanoma-like melanins
and contribute to their tendency to become pro-oxidatively
charged. In this context, the concept of a neurocristopathy
is supported by magnetic resonance studies that reveal
early metabolic changes, the occurrence of slow axonal
changes rather than acute ones, in MS, and a dilatation in
shape of perivascular spaces (Groeschel et al. 2006).
Conclusions
Behan and Chaudhuri (2010) have provided a stimulus to
further discussion on the concept of ‘neurocristopathy’ in
the pathogenesis of MS. In response to this stimulus, we
have taken tentative steps towards a testable unifying
hypothesis based on described exogenous and endogenous
factors predisposing to MS and centred on the biosynthesis
of a melanoma-like melanin. This, however, requires
experimental veriﬁcation by further studies. Whilst MS still
tightly holds some of its mysteries, light is penetrating the
darkness and we are convinced that the time has come
when an interdisciplinary programme of research could
reduce the current complexity to a simple testable unifying
hypothesis and to a rational approach to the development of
preventive and therapeutic strategies for this disease.
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